David J. Bentrem

Active 2000–2025

126
Papers
24,853
Citations
85
h-index
122
i10-index

Citations

Citations per year for David J. Bentrem1999: 1 citations2001: 14 citations2002: 12 citations2003: 21 citations2004: 17 citations2005: 11 citations2006: 20 citations2007: 34 citations2008: 71 citations2009: 95 citations2010: 130 citations2011: 161 citations2012: 212 citations2013: 166 citations2014: 194 citations2015: 206 citations2016: 193 citations2017: 214 citations2018: 208 citations2019: 850 citations2020: 871 citations2021: 748 citations2022: 638 citations2023: 464 citations2024: 879 citations2025: 344 citations2026: 13 citations2000: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,737 citing papers, 28.9% of this breakdownChina: 1,554 citing papers, 16.4% of this breakdownGermany: 532 citing papers, 5.6% of this breakdownItaly: 488 citing papers, 5.2% of this breakdownUnited Kingdom: 460 citing papers, 4.9% of this breakdownJapan: 354 citing papers, 3.8% of this breakdownNetherlands: 323 citing papers, 3.4% of this breakdownFrance: 285 citing papers, 3% of this breakdownCanada: 258 citing papers, 2.7% of this breakdownSouth Korea: 235 citing papers, 2.5% of this breakdownAustralia: 169 citing papers, 1.8% of this breakdownSpain: 164 citing papers, 1.7% of this breakdown
0%28.9%Other 20.1%

Fields

  • Medicine75.8%
  • Biochemistry, Genetics and Molecular Biology16.5%
  • Immunology and Microbiology4.2%
  • Engineering0.8%
  • Computer Science0.4%
  • Health Professions0.4%
  • Other1.9%

Topics

  • Pancreatic and Hepatic Oncology Research11%
  • Gastric Cancer Management and Outcomes5.1%
  • Esophageal Cancer Research and Treatment3.8%
  • Cancer Immunotherapy and Biomarkers2.8%
  • Cancer Genomics and Diagnostics2.7%
  • Cancer Cells and Metastasis2.2%
  • Other72.4%

Coauthors

All papers

Open in search
  1. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott I. Reznik, Robert E. Roses, Vivian E. Strong, Stacey Su, Hanlin L. Wang, Georgia L. Wiesner, Christopher G. Willett, Danny Yakoub, Harry H. Yoon, Nicole R. McMillian, Lenora A. Pluchino - Journal of the National Comprehensive Cancer Network 2022 cited by 1,703

  2. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , - Nature Genetics 2015 cited by 2,218

  3. Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George A. Poultsides, Scott I. Reznik, Robert E. Roses, Vivian E. Strong, Stacey Su, Hanlin L. Wang, Georgia L. Wiesner, Christopher G. Willett, Danny Yakoub, Harry H. Yoon, Nicole R. McMillian, Lenora A. Pluchino - Journal of the National Comprehensive Cancer Network 2023 cited by 520

  4. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George A. Poultsides, Robert E. Roses, Vivian E. Strong, Georgia L. Wiesner, Christopher G. Willett, Cameron D. Wright, Nicole R. McMillian, Lenora A. Pluchino - Journal of the National Comprehensive Cancer Network 2019 cited by 1,097

  5. Esophageal and Esophagogastric Junction Cancers, Version 1.2015

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas K. Varghese, M. Kay Washington, Christopher G. Willett, Cameron D. Wright, Debra Zelman, Nicole R. McMillian, Hema Sundar - Journal of the National Comprehensive Cancer Network 2015 cited by 653

  6. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Walter J. Scott, Vivian E. Strong, M. Kay Washington, Benny Weksler, Christopher G. Willett, Cameron D. Wright, Debra Zelman, Nicole R. McMillian, Hema Sundar - Journal of the National Comprehensive Cancer Network 2016 cited by 957

  7. Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer

    Authors: , , , , , , , - Annals of Surgery 2013 cited by 439

  8. A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Surgery 2016 cited by 284

  9. TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis

    Authors: , , , , , , , , , , , , , - Cancer Research 2016 cited by 197

  10. National Failure to Operate on Early Stage Pancreatic Cancer

    Authors: , , , , , - Annals of Surgery 2007 cited by 557

  11. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Travis Smith, Rebecca A. Snyder, Marina Talamonti, Sharon M. Weber, Adam C. Yopp, Henry A. Pitt, Clifford Y. Ko - JAMA 2023 cited by 124

  12. Gastric Cancer, Version 2.2013

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hema Sundar - Journal of the National Comprehensive Cancer Network 2013 cited by 515

  13. Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies

    Authors: , , , , , , , , - Cancers 2021 cited by 55

  14. Expression of RORγt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2012 cited by 203

  15. Environmental and Genetic Risk Factors for Gastric Cancer

    Authors: , - Cancer treatment and research 2022 cited by 74

  16. Quercetin Enhances the Anti-Tumor Effects of BET Inhibitors by Suppressing hnRNPA1

    Authors: , , , , , , , - International Journal of Molecular Sciences 2019 cited by 57

  17. Esophageal and Esophagogastric Junction Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the National Comprehensive Cancer Network 2011 cited by 335

  18. Wait Times for Cancer Surgery in the United States

    Authors: , , , , , , , - Annals of Surgery 2011 cited by 313

  19. Crosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor Progression

    Authors: , , , , , , , , , , - Clinical Cancer Research 2010 cited by 194

  20. β-Catenin Promotes Colitis and Colon Cancer Through Imprinting of Proinflammatory Properties in T Cells

    Authors: , , , , , , , , , , , , , , , - Science Translational Medicine 2014 cited by 156

  21. Iron drives anabolic metabolism through active histone demethylation and mTORC1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2023 cited by 38

  22. Adrenocortical carcinoma in the United States

    Authors: , , , , , , - Cancer 2008 cited by 481

  23. Comparison of Commission on Cancer–Approved and –Nonapproved Hospitals in the United States: Implications for Studies That Use the National Cancer Data Base

    Authors: , , , , - Journal of Clinical Oncology 2009 cited by 374

  24. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest

    Authors: , , , , , , , , , - Molecular Cancer 2006 cited by 184